<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK481904" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK481904/" /><meta name="ncbi_pagename" content="ISCA2-Related Mitochondrial Disorder - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>ISCA2-Related Mitochondrial Disorder - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="ISCA2-Related Mitochondrial Disorder" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2018/02/22" /><meta name="citation_author" content="Zuhair N Al-Hassnan" /><meta name="citation_author" content="Namik Kaya" /><meta name="citation_pmid" content="29470032" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK481904/" /><meta name="citation_keywords" content="Multiple Mitochondrial Dysfunction Syndrome 4" /><meta name="citation_keywords" content="Multiple Mitochondrial Dysfunction Syndrome 4" /><meta name="citation_keywords" content="Iron-sulfur cluster assembly 2 homolog, mitochondrial" /><meta name="citation_keywords" content="ISCA2" /><meta name="citation_keywords" content="ISCA2-Related Mitochondrial Disorder" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="ISCA2-Related Mitochondrial Disorder" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Zuhair N Al-Hassnan" /><meta name="DC.Contributor" content="Namik Kaya" /><meta name="DC.Date" content="2018/02/22" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK481904/" /><meta name="description" content="Infants with ISCA2-related mitochondrial disorder (IRMD) typically attain normal development in the first months of life. At age three to seven months, affected individuals usually present with a triad of neurodevelopmental regression, nystagmus with optic atrophy, and diffuse white matter disease. As the disease progresses, global psychomotor regression continues at a variable pace and seizures may develop. Affected children become vegetative within one to two years. During their vegetative state, which may persist for years, affected individuals are prone to recurrent chest infections that may require ventilator support. Most affected individuals die during early childhood." /><meta name="og:title" content="ISCA2-Related Mitochondrial Disorder" /><meta name="og:type" content="book" /><meta name="og:description" content="Infants with ISCA2-related mitochondrial disorder (IRMD) typically attain normal development in the first months of life. At age three to seven months, affected individuals usually present with a triad of neurodevelopmental regression, nystagmus with optic atrophy, and diffuse white matter disease. As the disease progresses, global psychomotor regression continues at a variable pace and seizures may develop. Affected children become vegetative within one to two years. During their vegetative state, which may persist for years, affected individuals are prone to recurrent chest infections that may require ventilator support. Most affected individuals die during early childhood." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK481904/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/isca2-mt-dis/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK481904/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8A25BDE0406A310000000003410143.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK481904_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK481904_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/isca1-mmds/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/ibmpfd/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK481904_"><span class="title" itemprop="name"><i>ISCA2</i>-Related Mitochondrial Disorder</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: Multiple Mitochondrial Dysfunction Syndrome 4</div><p class="contrib-group"><span itemprop="author">Zuhair N Al-Hassnan</span>, MD and <span itemprop="author">Namik Kaya</span>, PhD.</p><a data-jig="ncbitoggler" href="#__NBK481904_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK481904_ai__"><div class="contrib half_rhythm"><span itemprop="author">Zuhair N Al-Hassnan</span>, MD<div class="affiliation small">Department of Medical Genetics<br />King Faisal Specialist Hospital &#x00026; Research Center<br />Riyadh, Saudi Arabia<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="as.ude.crhsfk@nanssahz" class="oemail">as.ude.crhsfk@nanssahz</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Namik Kaya</span>, PhD<div class="affiliation small">Department of Medical Genetics<br />King Faisal Specialist Hospital &#x00026; Research Center<br />Riyadh, Saudi Arabia<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="as.ude.crhsfk@ayakn" class="oemail">as.ude.crhsfk@ayakn</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">February 22, 2018</span>.</p><p><em>Estimated reading time: 13 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="isca2-mt-dis.Summary" itemprop="description"><h2 id="_isca2-mt-dis_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Infants with <i>ISCA2</i>-related mitochondrial disorder (IRMD) typically attain normal development in the first months of life. At age three to seven months, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals usually present with a triad of neurodevelopmental regression, nystagmus with optic atrophy, and diffuse white matter disease. As the disease progresses, global psychomotor regression continues at a variable pace and seizures may develop. Affected children become vegetative within one to two years. During their vegetative state, which may persist for years, affected individuals are prone to recurrent chest infections that may require ventilator support. Most affected individuals die during early childhood.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of <i>ISCA2</i>-related mitochondrial disorder is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by the identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>ISCA2</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Treatment is primarily supportive and may require input from a geneticist, neurologist, dietician, and developmental specialist. A feeding tube (nasogastric or gastrostomy) is typically required. Standard treatment for epilepsy. Recurrent chest infections may require ventilator support in addition to antimicrobial therapy. Referral to early intervention services is recommended. For muscle tone abnormalities including hypertonia, baclofen and/or Botox<sup>&#x000ae;</sup> may be considered.</p><p><i>Prevention of secondary complications</i>: Constipation may become problematic and may require ensuring adequate hydration and/or treatment with stool softeners or laxatives.</p><p><i>Surveillance:</i> Periodic evaluation of swallowing function is suggested.</p></div><div><h4 class="inline">Genetic counseling.</h4><p><i>ISCA2</i>-related mitochondrial disorder is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual with IRMD has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives and prenatal testing for pregnancies at increased risk are possible if the <i>ISCA2</i> pathogenic variants in the family are known.</p></div></div><div id="isca2-mt-dis.Diagnosis"><h2 id="_isca2-mt-dis_Diagnosis_">Diagnosis</h2><p><i>ISCA2</i>-related mitochondrial disorder (IRMD) is a severe neurodegenerative condition; consensus clinical diagnostic criteria have not been published.</p><div id="isca2-mt-dis.Suggestive_Findings"><h3>Suggestive Findings</h3><p>IRMD <b>should be suspected</b> in infants with the following neurologic, ophthalmologic, head imaging, and supportive laboratory findings.</p><p><b>Neurologic findings</b></p><ul><li class="half_rhythm"><div>Progressive loss of developmental milestones, typically beginning between ages three and seven months</div></li><li class="half_rhythm"><div>Spasticity</div></li><li class="half_rhythm"><div>Impaired speech</div></li></ul><p><b>Ophthalmologic features</b></p><ul><li class="half_rhythm"><div>Optic atrophy</div></li><li class="half_rhythm"><div>Nystagmus</div></li></ul><p><b>Head MRI findings</b></p><ul><li class="half_rhythm"><div>Diffuse bilateral symmetric signal abnormality in cerebral white matter</div></li><li class="half_rhythm"><div>In some cases, signal abnormalities in the corpus callosum, internal capsule, midbrain, middle cerebellar peduncles, and cervical spinal cord</div></li></ul><p><b>Supportive laboratory findings</b></p><ul><li class="half_rhythm"><div><b>Biochemical screening</b></div><ul><li class="half_rhythm"><div>Serum and CSF lactate may be elevated, but this is not a consistent finding.</div></li><li class="half_rhythm"><div>Plasma and CSF glycine levels are usually elevated [<a class="bk_pop" href="#isca2-mt-dis.REF.alaimo.2018.537">Alaimo et al 2018</a>, <a class="bk_pop" href="#isca2-mt-dis.REF.alfadhel.2018.46">Alfadhel et al 2018</a>].</div></li><li class="half_rhythm"><div>Plasma acylcarnitine and urine organic acids analyses are usually unremarkable [<a class="bk_pop" href="#isca2-mt-dis.REF.alhassnan.2015.186">Al-Hassnan et al 2015</a>].</div></li></ul></li><li class="half_rhythm"><div><b>Respiratory chain enzyme analysis</b> on muscle tissue reveals deficient activity of complex II and IV [<a class="bk_pop" href="#isca2-mt-dis.REF.alaimo.2018.537">Alaimo et al 2018</a>, <a class="bk_pop" href="#isca2-mt-dis.REF.toldo.2018.805">Toldo et al 2018</a>].</div></li></ul><p>Note: (1) Respiratory chain enzyme analysis is not required to make the diagnosis. (2) More invasive testing that requires a skin or muscle biopsy sample may be bypassed in favor of <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> on a peripheral blood sample (see <a href="#isca2-mt-dis.Establishing_the_Diagnosis">Establishing the Diagnosis</a>).</p></div><div id="isca2-mt-dis.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of <i>ISCA2</i>-related mitochondrial disorder <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>ISCA2</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK481904/table/isca2-mt-dis.T.molecular_genetic_testing/?report=objectonly" target="object" rid-figpopup="figisca2mtdisTmoleculargenetictesting" rid-ob="figobisca2mtdisTmoleculargenetictesting">Table 1</a>)</p><p>Molecular genetic testing approaches can include use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, <b>more comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>, and (rarely) <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>.</p><p>Gene-targeted testing requires that the clinician determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing does not. Because the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of IRMD is similar to a wide range of neurodegenerative conditions, genomic testing is typically pursued first.</p><div id="isca2-mt-dis.Recommended_Genomic_Testing"><h4>Recommended Genomic Testing</h4><p><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>ISCA2</i> and other genes of interest (see <a href="#isca2-mt-dis.Differential_Diagnosis">Differential Diagnosis</a>) may be considered first. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p><p><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, mitochondrial sequencing, and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a> may be considered. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> or genes that results in a similar clinical presentation).</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p></div><div id="isca2-mt-dis.Further_Testing_to_Consider"><h4>Further Testing to Consider</h4><p><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> may (rarely) be considered if the clinical features are highly suggestive of IRMD. Only one <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified, and it is likely a <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a> [<a class="bk_pop" href="#isca2-mt-dis.REF.alhassnan.2015.186">Al-Hassnan et al 2015</a>]. Targeted analysis for this variant may be considered in <a class="def" href="/books/n/gene/glossary/def-item/consanguineous/">consanguineous</a> families from Saudi Arabia.</p><div id="isca2-mt-dis.T.molecular_genetic_testing" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>ISCA2</i>-Related Mitochondrial Disorder</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK481904/table/isca2-mt-dis.T.molecular_genetic_testing/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__isca2-mt-dis.T.molecular_genetic_testing_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_isca2-mt-dis.T.molecular_genetic_testing_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_isca2-mt-dis.T.molecular_genetic_testing_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_isca2-mt-dis.T.molecular_genetic_testing_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_isca2-mt-dis.T.molecular_genetic_testing_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>ISCA2</i></td><td headers="hd_h_isca2-mt-dis.T.molecular_genetic_testing_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Targeted testing for c.229G&#x0003e;A <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>&#x000a0;<sup>3</sup></td><td headers="hd_h_isca2-mt-dis.T.molecular_genetic_testing_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">18/19&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_isca2-mt-dis.T.molecular_genetic_testing_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>5</sup></td><td headers="hd_h_isca2-mt-dis.T.molecular_genetic_testing_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~100%&#x000a0;<sup>3</sup></td></tr><tr><td headers="hd_h_isca2-mt-dis.T.molecular_genetic_testing_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>6</sup></td><td headers="hd_h_isca2-mt-dis.T.molecular_genetic_testing_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>7</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="isca2-mt-dis.TF.1.1"><p class="no_margin">See <a href="/books/NBK481904/#isca2-mt-dis.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="isca2-mt-dis.TF.1.2"><p class="no_margin">See <a href="#isca2-mt-dis.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="isca2-mt-dis.TF.1.3"><p class="no_margin">One pathogenic <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a> has been reported [<a class="bk_pop" href="#isca2-mt-dis.REF.alhassnan.2015.186">Al-Hassnan et al 2015</a>]. Compound heterozygosity for two variants (c.295delT and c.334A&#x0003e;G) has been reported in a single <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual [<a class="bk_pop" href="#isca2-mt-dis.REF.toldo.2018.805">Toldo et al 2018</a>], whose features differed slightly from the originally described cohort of individuals, who were all <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for the founder variant.</p></div></dd><dt>4. </dt><dd><div id="isca2-mt-dis.TF.1.4"><p class="no_margin"><a class="bk_pop" href="#isca2-mt-dis.REF.alazami.2015.148">Alazami et al [2015]</a>, <a class="bk_pop" href="#isca2-mt-dis.REF.alhassnan.2015.186">Al-Hassnan et al [2015]</a>, <a class="bk_pop" href="#isca2-mt-dis.REF.alaimo.2018.537">Alaimo et al [2018]</a>, <a class="bk_pop" href="#isca2-mt-dis.REF.alfadhel.2018.46">Alfadhel et al [2018]</a>, <a class="bk_pop" href="#isca2-mt-dis.REF.toldo.2018.805">Toldo et al [2018]</a></p></div></dd><dt>5. </dt><dd><div id="isca2-mt-dis.TF.1.5"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>6. </dt><dd><div id="isca2-mt-dis.TF.1.6"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>7. </dt><dd><div id="isca2-mt-dis.TF.1.7"><p class="no_margin">No data on detection rate of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> are available.</p></div></dd></dl></div></div></div></div></div></div><div id="isca2-mt-dis.Clinical_Characteristics"><h2 id="_isca2-mt-dis_Clinical_Characteristics_">Clinical Characteristics</h2><div id="isca2-mt-dis.Clinical_Description"><h3>Clinical Description</h3><p>Only 20 individuals with this condition have been reported [<a class="bk_pop" href="#isca2-mt-dis.REF.alazami.2015.148">Alazami et al 2015</a>, <a class="bk_pop" href="#isca2-mt-dis.REF.alhassnan.2015.186">Al-Hassnan et al 2015</a>, <a class="bk_pop" href="#isca2-mt-dis.REF.alaimo.2018.537">Alaimo et al 2018</a>, <a class="bk_pop" href="#isca2-mt-dis.REF.alfadhel.2018.46">Alfadhel et al 2018</a>, <a class="bk_pop" href="#isca2-mt-dis.REF.toldo.2018.805">Toldo et al 2018</a>]. Infants with IRMD attain normal development in the first months of life. At age three to seven months 18 out of 18 individuals reported have experienced progressive loss of milestones with irritability, inattention, and inability to perform previously acquired motor skills. Nystagmus on presentation has been reported in eight of 12 individuals assessed. Clinical evaluation reveals central hypotonia that progresses to limb spasticity and hyperreflexia (18/18). Optic atrophy with progressive loss of vision has been observed in 18 of 18 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals evaluated. As the disease progresses, global psychomotor regression continues at a variable pace and seizures (3/10) may develop. Seizures are generalized tonic-clonic and are responsive to anticonvulsant treatment [<a class="bk_pop" href="#isca2-mt-dis.REF.alfadhel.2018.46">Alfadhel et al 2018</a>]. Affected children become vegetative within one to two years. During their vegetative state, which may persist for years, affected individuals are prone to recurrent chest infections that may require ventilator support. Most affected individuals die during early childhood. As the disease is severe with no known cure, continuing to provide supportive care, including invasive ventilation, must be seriously reviewed. Progressive multiorgan (liver, kidney, heart) failure has not been observed in this condition.</p><p>Dysmorphic features (low-set ears, broad nasal bridge, short fourth metacarpals, cutaneous toe syndactyly) have been rarely observed (2/18) [<a class="bk_pop" href="#isca2-mt-dis.REF.alaimo.2018.537">Alaimo et al 2018</a>].</p><p>A rapidly progressive severe course with neonatal leukoencephalopathy and death at age three months was reported in a single <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual who had <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> novel (non-founder) pathogenic <i>ISCA2</i> variants [<a class="bk_pop" href="#isca2-mt-dis.REF.toldo.2018.805">Toldo et al 2018</a>].</p><p>Since so few cases have been identified, understanding of the clinical phenotypic spectrum and natural history continues to evolve.</p><p><b>Neuroimaging</b> with brain MRI typically demonstrates extensive diffuse bilateral symmetric signal abnormality in cerebral periventricular white matter, most often sparing the U-fibers. These changes are hyperintense on T<sub>2</sub>-weighted images. Signal abnormalities can also be seen in other areas of the brain (see <a href="#isca2-mt-dis.Suggestive_Findings">Suggestive Findings</a>), although the basal ganglia are usually spared [<a class="bk_pop" href="#isca2-mt-dis.REF.alhassnan.2015.186">Al-Hassnan et al 2015</a>]. High lactate, glycine, and glutamine/glutamate peaks may also be seen in brain MR spectroscopy [<a class="bk_pop" href="#isca2-mt-dis.REF.alaimo.2018.537">Alaimo et al 2018</a>, <a class="bk_pop" href="#isca2-mt-dis.REF.alfadhel.2018.46">Alfadhel et al 2018</a>, <a class="bk_pop" href="#isca2-mt-dis.REF.toldo.2018.805">Toldo et al 2018</a>].</p><p><b>Muscle biopsy</b> from one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has been analyzed; it demonstrated minimal histologic changes [<a class="bk_pop" href="#isca2-mt-dis.REF.alhassnan.2015.186">Al-Hassnan et al 2015</a>]. The hematoxylin- and eosin-stained frozen sections of the skeletal muscle showed mild to moderate variation in myofiber size with moderately to severely atrophic fibers in a random distribution. There were no significant myopathic features, such as fiber degeneration, regeneration, or hypertrophy. Ragged red fibers were not observed. Ultrastructural examination of a representative preserved area showed normal myofibrillar organization and cellular organelles with only a few small accumulations of structurally normal mitochondria.</p></div><div id="isca2-mt-dis.GenotypePhenotype_Correlati"><h3>Genotype-Phenotype Correlations</h3><p>One <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> infant who had diffuse hypotonia, a rapidly progressive course, and no optic atrophy was found to have <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> novel (non-founder) pathogenic <i>ISCA2</i> variants (see <a class="figpopup" href="/books/NBK481904/table/isca2-mt-dis.T.molecular_genetic_testing/?report=objectonly" target="object" rid-figpopup="figisca2mtdisTmoleculargenetictesting" rid-ob="figobisca2mtdisTmoleculargenetictesting">Table 1</a>, footnote 3) [<a class="bk_pop" href="#isca2-mt-dis.REF.toldo.2018.805">Toldo et al 2018</a>]. It is unclear whether the atypical presentation was a result of the novel variants or an instance of the clinical variability often seen among individuals with the same condition.</p></div><div id="isca2-mt-dis.Prevalence"><h3>Prevalence</h3><p>The prevalence of IRMD is unknown. Twenty <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals from 18 families have been reported in the literature [<a class="bk_pop" href="#isca2-mt-dis.REF.alazami.2015.148">Alazami et al 2015</a>, <a class="bk_pop" href="#isca2-mt-dis.REF.alhassnan.2015.186">Al-Hassnan et al 2015</a>, <a class="bk_pop" href="#isca2-mt-dis.REF.alaimo.2018.537">Alaimo et al 2018</a>, <a class="bk_pop" href="#isca2-mt-dis.REF.alfadhel.2018.46">Alfadhel et al 2018</a>]. Most (19/20) of the affected individuals reported are from Saudi Arabia, which may suggest a higher prevalence of the disorder in Arabs. A single affected individual from Italy has been reported [<a class="bk_pop" href="#isca2-mt-dis.REF.toldo.2018.805">Toldo et al 2018</a>].</p></div></div><div id="isca2-mt-dis.Genetically_Related_Allelic"><h2 id="_isca2-mt-dis_Genetically_Related_Allelic_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with pathogenic variants in <i>ISCA2</i>.</p></div><div id="isca2-mt-dis.Differential_Diagnosis"><h2 id="_isca2-mt-dis_Differential_Diagnosis_">Differential Diagnosis</h2><p>The differential diagnosis of neurologic regression with white matter disease in infancy is extensive. Diagnostic algorithms for genetic leukodystrophy disorders have been published (see <a href="/books/n/gene/leukodys-ov/">Leukodystrophy Overview</a>). In <i>ISCA2</i>-related mitochondrial disorder (IRMD), the constellation of extensive periventricular leukodystrophy, optic atrophy, and biochemical and/or histopathologic evidence of mitochondrial involvement is suggestive of the disorder but can also be seen in other conditions.</p><div id="isca2-mt-dis.T.disorders_to_consider_in" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Disorders to Consider in the Differential Diagnosis of <i>ISCA2</i>-Related Mitochondrial Disorder (IRMD)</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK481904/table/isca2-mt-dis.T.disorders_to_consider_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__isca2-mt-dis.T.disorders_to_consider_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_2" style="text-align:left;vertical-align:middle;">Gene(s)</th><th id="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_3" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Clinical Features of This Disorder</th></tr><tr><th headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_4" id="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Overlapping w/IRMD</th><th headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_4" id="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distinguishing from IRMD</th></tr></thead><tbody><tr><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Multiple mitochondrial dysfunctions syndrome 1</td><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>NFU1</i></td><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_4 hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Feeding difficulties</div></li><li class="half_rhythm"><div>Muscle weakness</div></li><li class="half_rhythm"><div>Decreasing responsiveness</div></li><li class="half_rhythm"><div>Neurologic regression</div></li><li class="half_rhythm"><div>White matter lesions on brain MRI</div></li><li class="half_rhythm"><div>Lactic acidosis</div></li><li class="half_rhythm"><div>&#x02193; activity of mt respiratory complexes</div></li></ul></td><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_4 hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Pulmonary hypertension</div></li><li class="half_rhythm"><div>Obstructive vasculopathy</div></li><li class="half_rhythm"><div>Spongiform degeneration &#x00026; white matter necrosis</div></li><li class="half_rhythm"><div>Onset soon after birth</div></li></ul></td></tr><tr><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Multiple mitochondrial dysfunctions syndrome 2</td><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>BOLA3</i></td><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_4 hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Optic atrophy</div></li><li class="half_rhythm"><div>Visual impairment</div></li><li class="half_rhythm"><div>Spasticity</div></li><li class="half_rhythm"><div>Leukodystrophy</div></li><li class="half_rhythm"><div>Spinal cord lesions</div></li><li class="half_rhythm"><div>Lactic acidosis</div></li><li class="half_rhythm"><div>Onset in infancy</div></li><li class="half_rhythm"><div>&#x02193; activity of mt respiratory complexes</div></li></ul></td><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_4 hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Cardiomyopathy</div></li><li class="half_rhythm"><div>Hepatomegaly</div></li><li class="half_rhythm"><div>Extrapyramidal signs</div></li><li class="half_rhythm"><div>Ataxia</div></li><li class="half_rhythm"><div>Myoclonus</div></li></ul></td></tr><tr><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Multiple mitochondrial dysfunctions syndrome 3</td><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>IBA57</i></td><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_4 hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>White matter abnormalities</div></li><li class="half_rhythm"><div>Lactic acidosis</div></li><li class="half_rhythm"><div>&#x02193; activity of mt respiratory complexes</div></li></ul></td><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_4 hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Onset in utero</div></li><li class="half_rhythm"><div>Intrauterine growth restriction</div></li><li class="half_rhythm"><div>Microcephaly</div></li><li class="half_rhythm"><div>Dysmorphic features (retrognathia, high-arched palate, widely spaced nipples)</div></li><li class="half_rhythm"><div>Arthrogryposis</div></li><li class="half_rhythm"><div>Severe hypotonia</div></li><li class="half_rhythm"><div>Polymicrogyria</div></li><li class="half_rhythm"><div>Hypoplasia of the corpus callosum</div></li><li class="half_rhythm"><div>Hypoplasia of the medulla oblongata</div></li></ul></td></tr><tr><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/isca1-mmds/"><i>ISCA1</i>-related multiple mitochondrial dysfunctions syndrome</a></td><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ISCA1</i></td><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_4 hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Neurologic regression</div></li><li class="half_rhythm"><div>White matter abnormalities</div></li><li class="half_rhythm"><div>Lactic acidosis</div></li></ul></td><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_4 hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Abnormalities of cortical migration</td></tr><tr><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/mld/">Metachromatic leukodystrophy</a></td><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ARSA</i> or <i>PSAP</i></td><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_4 hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Neurologic regression</div></li><li class="half_rhythm"><div>Leukodystrophy</div></li><li class="half_rhythm"><div>Spasticity</div></li></ul>
<ul><li class="half_rhythm"><div>Optic atrophy</div></li></ul></td><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_4 hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02191; urinary sulfatide excretion</td></tr><tr><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/krabbe/">Krabbe disease</a></td><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GALC</i></td><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_4 hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Neurologic regression</div></li><li class="half_rhythm"><div>Leukodystrophy</div></li><li class="half_rhythm"><div>Spasticity</div></li></ul>
<ul><li class="half_rhythm"><div>Optic atrophy</div></li></ul></td><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_4 hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pattern of MRI findings, incl involvement of thalami &#x00026; caudate</td></tr><tr><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/lbsl/">Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation</a></td><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DARS2</i></td><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_4 hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Neurologic regression</div></li></ul>
<ul><li class="half_rhythm"><div>&#x02191; lactate in serum &#x00026; MR spectroscopy</div></li></ul></td><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_4 hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pattern of MRI findings</td></tr><tr><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/cach/">Childhood ataxia with central nervous system hypomyelination/vanishing white matter</a></td><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>EIF2B1</i><br /><i>EIF2B2</i><br /><i>EIF2B3</i><br /><i>EIF2B4</i><br /><i>EIF2B5</i></td><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_4 hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Neurologic regression</div></li><li class="half_rhythm"><div>Leukodystrophy</div></li><li class="half_rhythm"><div>Spasticity</div></li><li class="half_rhythm"><div>Optic atrophy</div></li></ul></td><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_4 hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Unsteady gait</div></li><li class="half_rhythm"><div>Pattern of MRI findings</div></li><li class="half_rhythm"><div>Ovarian dysgenesis in females</div></li></ul></td></tr><tr><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/canavan/">Canavan disease</a></td><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ASPA</i></td><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_4 hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Neurologic regression</div></li><li class="half_rhythm"><div>Leukodystrophy</div></li><li class="half_rhythm"><div>Optic atrophy</div></li></ul></td><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_4 hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Macrocephaly</div></li><li class="half_rhythm"><div>Pattern of MRI findings</div></li><li class="half_rhythm"><div>Increased N-acetyl-L-aspartate in urine</div></li></ul></td></tr><tr><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/alexander/">Alexander disease</a></td><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GFAP</i></td><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_4 hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Neurologic regression</div></li><li class="half_rhythm"><div>Leukodystrophy</div></li><li class="half_rhythm"><div>Spasticity</div></li><li class="half_rhythm"><div>Optic atrophy</div></li></ul></td><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_4 hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Macrocephaly</div></li><li class="half_rhythm"><div>Pattern of MRI findings</div></li></ul></td></tr><tr><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/narp/">Leigh syndrome</a></td><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hetero-geneous</td><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR<br />XL<br />mt</td><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_4 hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Neurologic regression</div></li><li class="half_rhythm"><div>&#x02191; lactate in serum &#x00026; MR spectroscopy</div></li></ul></td><td headers="hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_1_4 hd_h_isca2-mt-dis.T.disorders_to_consider_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Hypertrophic cardiomyopathy</div></li><li class="half_rhythm"><div>Hypertrichosis</div></li><li class="half_rhythm"><div>Renal tubulopathy</div></li><li class="half_rhythm"><div>Liver involvement</div></li><li class="half_rhythm"><div>Bilateral symmetric T<sub>2</sub>-weighted hyperintensities in the basal ganglia &#x00026;/or brain stem on MRI</div></li><li class="half_rhythm"><div>Basal ganglia involvement</div></li></ul></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; mt = mitochondrial; XL = <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a></p></div></dd></dl></div></div></div><p><b>Other leukodystrophies and lysosomal storage diseases.</b> Other progressive degenerative disorders that manifest in infancy can mimic IRMD. In the presence of leukodystrophy, other conditions to consider include <a href="/books/n/gene/pmd/">Pelizaeus-Merzbacher disease</a> and <a href="/books/n/gene/tay-sachs/">GM2 gangliosidoses</a> (Tay-Sachs disease [hexosaminidase A deficiency] and Sandhoff disease).</p><p>See <a href="https://omim.org/phenotypicSeries/PS605711" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Multiple Mitochondrial Dysfunctions Syndrome: OMIM Phenotypic Series</a> to view genes associated with this <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in OMIM.</p></div><div id="isca2-mt-dis.Management"><h2 id="_isca2-mt-dis_Management_">Management</h2><div id="isca2-mt-dis.Evaluations_Following_Initi"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with <i>ISCA2</i>-related mitochondrial disorder (IRMD), the following evaluations are recommended if they have not already been completed:</p><ul><li class="half_rhythm"><div>Neurologic evaluation to assess for tone and spasticity</div></li><li class="half_rhythm"><div>Ophthalmologic examination to assess for optic atrophy</div></li><li class="half_rhythm"><div>Brain MRI and MRS</div></li><li class="half_rhythm"><div>Assessment of feeding problems, with consideration of a swallowing study</div></li><li class="half_rhythm"><div>Assessment of nutritional status by monitoring growth parameters and serum chemistries, such as albumin and total protein</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="isca2-mt-dis.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>The mainstay of treatment is supportive and is best provided by a multidisciplinary team including a geneticist, neurologist, and dietician.</p><p>Feeding via nasogastric tube or gastrostomy will be required in most cases.</p><p>Standard treatment for epilepsy is indicated for those who have seizures.</p><p>Recurrent chest infections may require ventilator support in addition to antimicrobial therapy.</p><div id="isca2-mt-dis.Developmental_Delay__Intell"><h4>Developmental Delay / Intellectual Disability Management Issues</h4><p>The following information represents typical management recommendations for individuals with developmental delay / intellectual disability in the United States; standard recommendations may vary from country to country.</p><p><b>Ages 0-3 years.</b> Referral to an early intervention program is recommended for access to occupational, physical, speech, and feeding therapy. In the US, early intervention is a federally funded program available in all states.</p><p><b>Ages 3-5 years.</b> In the US, developmental preschool through the local public school district is recommended. Before placement, an evaluation is made to determine needed services and therapies and an individualized education plan (IEP) is developed.</p><p><b>All ages.</b> Consultation with a developmental pediatrician is recommended to ensure the involvement of appropriate community, state, and educational agencies and to support parents in maximizing quality of life. Some issues to consider:</p><ul><li class="half_rhythm"><div>Private supportive therapies based on the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual's needs may be considered. Specific recommendations regarding type of therapy can be made by a developmental pediatrician.</div></li><li class="half_rhythm"><div>In the US:</div><ul><li class="half_rhythm"><div>Developmental Disabilities Administration (DDA) enrollment is recommended. DDA is a public agency that provides services and support to qualified individuals. Eligibility differs by state but is typically determined by diagnosis and/or associated cognitive/adaptive disabilities.</div></li><li class="half_rhythm"><div>Families with limited income and resources may also qualify for supplemental security income (SSI) for their child with a disability.</div></li></ul></li></ul></div><div id="isca2-mt-dis.Gross_Motor_Dysfunction"><h4>Gross Motor Dysfunction</h4><p>Physical therapy is recommended to maximize mobility.</p><p>Consider use of durable medical equipment as needed (e.g., wheelchairs, walkers, bath chairs, orthotics, adaptive strollers).</p></div></div><div id="isca2-mt-dis.Prevention_of_Secondary_Com"><h3>Prevention of Secondary Complications</h3><p>With the progression of the disease, constipation can be a problem. Adequate hydration, stool softeners, and laxatives may help in avoiding severe constipation.</p></div><div id="isca2-mt-dis.Surveillance"><h3>Surveillance</h3><p>Periodic evaluation of swallowing function is suggested. Abnormal swallowing may prompt consideration of placement of a feeding tube.</p></div><div id="isca2-mt-dis.Evaluation_of_Relatives_at"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#isca2-mt-dis.Related_Genetic_Counseling">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="isca2-mt-dis.Therapies_Under_Investigati"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder</p></div></div><div id="isca2-mt-dis.Genetic_Counseling"><h2 id="_isca2-mt-dis_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="isca2-mt-dis.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><i>ISCA2</i>-related mitochondrial disorder is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are obligate heterozygotes (i.e., carriers of one <i>ISCA2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Individuals with <i>ISCA2</i>-related mitochondrial disorder are not known to reproduce.</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of an <i>ISCA2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="isca2-mt-dis.Carrier_Heterozygote_Detect"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the <i>ISCA2</i> pathogenic variants in the family.</p></div><div id="isca2-mt-dis.Related_Genetic_Counseling"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are carriers or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="isca2-mt-dis.Prenatal_Testing_and_Preimp"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>ISCA2</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="isca2-mt-dis.Resources"><h2 id="_isca2-mt-dis_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Mito Foundation (formerly the Australian Mitochondrial Disease Foundation)</b></div><div>21 Mary Street</div><div>Suite 3</div><div>Surry Hills New South Wales 2010</div><div>Australia</div><div><b>Phone:</b> 61-1-300-977-180</div><div><b>Fax:</b> 61-2-9999-3474</div><div><b>Email:</b> info@mito.org.au</div><div><a href="https://www.mito.org.au/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.mito.org.au</a></div></li><li class="half_rhythm"><div><b>United Mitochondrial Disease Foundation (UMDF)</b></div><div>8085 Saltsburg Road</div><div>Suite 201</div><div>Pittsburg PA 15239</div><div><b>Phone:</b> 888-317-8633 (toll-free); 412-793-8077</div><div><b>Fax:</b> 412-793-6477</div><div><b>Email:</b> info@umdf.org</div><div><a href="http://www.umdf.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.umdf.org</a></div></li><li class="half_rhythm"><div><b>Mitochondrial Disease Registry and Tissue Bank</b></div><div>Massachusetts General Hospital</div><div>185 Cambridge Street</div><div>Simches Research Building 5-238</div><div>Boston MA 02114</div><div><b>Phone:</b> 617-726-5718</div><div><b>Fax:</b> 617-724-9620</div><div><b>Email:</b> nslate@partners.org</div></li><li class="half_rhythm"><div><b>RDCRN Patient Contact Registry: North American Mitochondrial Disease Consortium</b></div><div><a href="https://www.rarediseasesnetwork.org/cms/namdc" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Patient Contact Registry</a></div></li></ul></div><div id="isca2-mt-dis.Molecular_Genetics"><h2 id="_isca2-mt-dis_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="isca2-mt-dis.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>ISCA2-Related Mitochondrial Disorder: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK481904/table/isca2-mt-dis.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__isca2-mt-dis.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_isca2-mt-dis.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_isca2-mt-dis.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_isca2-mt-dis.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_isca2-mt-dis.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_isca2-mt-dis.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_isca2-mt-dis.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/122961" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>ISCA2</i></a></td><td headers="hd_b_isca2-mt-dis.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=122961" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">14q24<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_isca2-mt-dis.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q86U28" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Iron-sulfur cluster assembly 2 homolog, mitochondrial</a></td><td headers="hd_b_isca2-mt-dis.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=ISCA2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ISCA2</a></td><td headers="hd_b_isca2-mt-dis.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=ISCA2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ISCA2</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="isca2-mt-dis.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="isca2-mt-dis.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for ISCA2-Related Mitochondrial Disorder (<a href="/omim/615317,616370" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK481904/table/isca2-mt-dis.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__isca2-mt-dis.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/615317" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">615317</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">IRON-SULFUR CLUSTER ASSEMBLY 2; ISCA2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/616370" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">616370</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4</td></tr></tbody></table></div></div><p><b>Gene structure.</b> The longest transcript of <i>ISCA2</i>, <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_194279.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_194279.3</a>, has four exons. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>, transcript, and protein information, see <a href="/books/NBK481904/#isca2-mt-dis.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> One pathogenic <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a> has been reported to date [<a class="bk_pop" href="#isca2-mt-dis.REF.alazami.2015.148">Alazami et al 2015</a>, <a class="bk_pop" href="#isca2-mt-dis.REF.alhassnan.2015.186">Al-Hassnan et al 2015</a>, <a class="bk_pop" href="#isca2-mt-dis.REF.alaimo.2018.537">Alaimo et al 2018</a>, <a class="bk_pop" href="#isca2-mt-dis.REF.alfadhel.2018.46">Alfadhel et al 2018</a>]. <a class="bk_pop" href="#isca2-mt-dis.REF.toldo.2018.805">Toldo et al [2018]</a> reported a single <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual who was a compound <a class="def" href="/books/n/gene/glossary/def-item/heterozygote/">heterozygote</a> for novel <i>ISCA2</i> variants (<a class="figpopup" href="/books/NBK481904/table/isca2-mt-dis.T.isca2_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figisca2mtdisTisca2pathogenicvariants" rid-ob="figobisca2mtdisTisca2pathogenicvariants">Table 3</a>).</p><div id="isca2-mt-dis.T.isca2_pathogenic_variants" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p><i>ISCA2</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK481904/table/isca2-mt-dis.T.isca2_pathogenic_variants/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__isca2-mt-dis.T.isca2_pathogenic_variants_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_isca2-mt-dis.T.isca2_pathogenic_variants_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_isca2-mt-dis.T.isca2_pathogenic_variants_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_isca2-mt-dis.T.isca2_pathogenic_variants_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_isca2-mt-dis.T.isca2_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.229G&#x0003e;A</td><td headers="hd_h_isca2-mt-dis.T.isca2_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly77Ser</td><td headers="hd_h_isca2-mt-dis.T.isca2_pathogenic_variants_1_1_1_3" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_194279.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_194279<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="https://www.ncbi.nlm.nih.gov/protein/NP_919255.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_919255<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_isca2-mt-dis.T.isca2_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.295delT&#x000a0;<sup>1</sup></td><td headers="hd_h_isca2-mt-dis.T.isca2_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Phe99LeufsTer18</td></tr><tr><td headers="hd_h_isca2-mt-dis.T.isca2_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.334A&#x0003e;G&#x000a0;<sup>1</sup></td><td headers="hd_h_isca2-mt-dis.T.isca2_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser112Gly</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="isca2-mt-dis.TF.3.1"><p class="no_margin"><a class="bk_pop" href="#isca2-mt-dis.REF.toldo.2018.805">Toldo et al [2018]</a></p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The <i>ISCA2</i>
<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_194279.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_194279.3</a> transcript encodes the 154-amino-acid protein iron-sulfur cluster assembly 2 homolog, mitochondrial (<a href="https://www.ncbi.nlm.nih.gov/protein/NP_919255.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_919255.2</a>). It is an A-type iron-sulfur cluster (ISC) protein that has a critical functional <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> for iron-sulfur (Fe-S) biogenesis. The protein helps in maturation of mitochondrial iron-sulfur cluster assembly.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Experimental studies indicate that p.Gly77Ser leads to reduced complex II and VI activity in the tested patients' muscle tissues [<a class="bk_pop" href="#isca2-mt-dis.REF.alaimo.2018.537">Alaimo et al 2018</a>, <a class="bk_pop" href="#isca2-mt-dis.REF.toldo.2018.805">Toldo et al 2018</a>]. Loss of ISCA2 has been shown to diminish mitochondrial membrane potential, the mitochondrial network, basal and maximal respiration, and ATP production and to disrupt the 4Fe-4S cluster machinery [<a class="bk_pop" href="#isca2-mt-dis.REF.alaimo.2018.537">Alaimo et al 2018</a>].</p></div><div id="isca2-mt-dis.References"><h2 id="_isca2-mt-dis_References_">References</h2><div id="isca2-mt-dis.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="isca2-mt-dis.REF.alaimo.2018.537">Alaimo JT, Besse A, Alston CL, Pang K, Appadurai V, Samanta M, Smpokou P, McFarland R, Taylor RW, Bonnen PE. Loss-of-function mutations in ISCA2 disrupt 4Fe-4S cluster machinery and cause a fatal leukodystrophy with hyperglycinemia and mtDNA depletion. <span><span class="ref-journal">Hum Mutat. </span>2018;<span class="ref-vol">39</span>:537–49.</span> [<a href="/pmc/articles/PMC5839994/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5839994</span></a>] [<a href="/pubmed/29297947" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29297947</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="isca2-mt-dis.REF.alazami.2015.148">Alazami AM, Patel N, Shamseldin HE, Anazi S, Al-Dosari MS, Alzahrani F, Hijazi H, Alshammari M, Aldahmesh MA, Salih MA, Faqeih E, Alhashem A, Bashiri FA, Al-Owain M, Kentab AY, Sogaty S, Al Tala S, Temsah MH, Tulbah M, Aljelaify RF, Alshahwan SA, Seidahmed MZ, Alhadid AA, Aldhalaan H, AlQallaf F, Kurdi W, Alfadhel M, Babay Z, Alsogheer M, Kaya N, Al-Hassnan ZN, Abdel-Salam GM, Al-Sannaa N, Al Mutairi F, El Khashab HY, Bohlega S, Jia X, Nguyen HC, Hammami R, Adly N, Mohamed JY, Abdulwahab F, Ibrahim N, Naim EA, Al-Younes B, Meyer BF, Hashem M, Shaheen R, Xiong Y, Abouelhoda M, Aldeeri AA, Monies DM, Alkuraya FS. Accelerating novel candidate gene discovery in neurogenetic disorders via whole-exome sequencing of prescreened multiplex consanguineous families. <span><span class="ref-journal">Cell Rep. </span>2015;<span class="ref-vol">10</span>:148–61.</span> [<a href="/pubmed/25558065" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25558065</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="isca2-mt-dis.REF.alfadhel.2018.46">Alfadhel M, Nashabat M, Alrifai MT, Alshaalan H, Al Mutairi F, Al-Shahrani SA, Plecko B, Almass R, Alsagob M, Almutairi FB, Al-Rumayyan A, Al-Twaijri W, Al-Owain M, Taylor RW, Kaya N. Further delineation of the phenotypic spectrum of ISCA2 defect: a report of ten new cases. <span><span class="ref-journal">Eur J Paediatr Neurol. </span>2018;<span class="ref-vol">22</span>:46–55.</span> [<a href="/pubmed/29122497" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29122497</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="isca2-mt-dis.REF.alhassnan.2015.186">Al-Hassnan ZN, Al-Dosary M, Alfadhel M, Faqeih EA, Alsagob M, Kenana R, Almass R, Al-Harazi OS, Al-Hindi H, Malibari OI, Almutari FB, Tulbah S, Alhadeq F, Al-Sheddi T, Alamro R, AlAsmari A, Almuntashri M, Alshaalan H, Al-Mohanna FA, Colak D, Kaya N. ISCA2 mutation causes infantile neurodegenerative mitochondrial disorder. <span><span class="ref-journal">J Med Genet. </span>2015;<span class="ref-vol">52</span>:186–94.</span> [<a href="/pubmed/25539947" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25539947</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="isca2-mt-dis.REF.toldo.2018.805">Toldo I, Nosadini M, Boscardin C, Talenti G, Manara R, Lamantea E, Legati A, Ghezzi D, Perilongo G, Sartori S. Neonatal mitochondrial leukoencephalopathy with brain and spinal involvement and high lactate: expanding the phenotype of ISCA2 gene mutations. <span><span class="ref-journal">Metab Brain Dis. </span>2018;<span class="ref-vol">33</span>:805–12.</span> [<a href="/pubmed/29359243" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29359243</span></a>]</div></li></ul></div></div><div id="isca2-mt-dis.Chapter_Notes"><h2 id="_isca2-mt-dis_Chapter_Notes_">Chapter Notes</h2><div id="isca2-mt-dis.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>22 February 2018 (ma) Review posted live</div></li><li class="half_rhythm"><div>31 July 2017 (znah) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK481904</span><span class="label">PMID: <a href="/pubmed/29470032" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">29470032</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/isca1-mmds/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/ibmpfd/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK481904&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK481904/?report=reader">PubReader</a></li><li><a href="/books/NBK481904/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK481904" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK481904" style="display:none" title="Cite this Page"><div class="bk_tt">Al-Hassnan ZN, Kaya N. ISCA2-Related Mitochondrial Disorder. 2018 Feb 22. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK481904/pdf/Bookshelf_NBK481904.pdf">PDF version of this page</a> (437K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#isca2-mt-dis.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#isca2-mt-dis.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#isca2-mt-dis.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#isca2-mt-dis.Genetically_Related_Allelic" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#isca2-mt-dis.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#isca2-mt-dis.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#isca2-mt-dis.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#isca2-mt-dis.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#isca2-mt-dis.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#isca2-mt-dis.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#isca2-mt-dis.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=122961[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">ISCA2</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=4502304" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=4502304" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=4502304" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=4502304" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31580634" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">ISCA1</i>-Related Multiple Mitochondrial Dysfunctions Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">ISCA1</i>-Related Multiple Mitochondrial Dysfunctions Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Shukla A, Narayanan DL, Kaur P, Girisha KM. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301501" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Polycystic Kidney Disease, Autosomal Recessive</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Polycystic Kidney Disease, Autosomal Recessive<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Sweeney WE, Avner ED. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301762" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">SUCLA2</i>-Related Mitochondrial DNA Depletion Syndrome, Encephalomyopathic Form with Methylmalonic Aciduria</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">SUCLA2</i>-Related Mitochondrial DNA Depletion Syndrome, Encephalomyopathic Form with Methylmalonic Aciduria<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">El-Hattab AW, Scaglia F. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/23230576" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">TK2</i>-Related Mitochondrial DNA Maintenance Defect, Myopathic Form</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">TK2</i>-Related Mitochondrial DNA Maintenance Defect, Myopathic Form<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Wang J, El-Hattab AW, Wong LJC. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/30234940" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Asparagine Synthetase Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Asparagine Synthetase Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Alfadhel M, El-Hattab AW. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=29470032" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=29470032" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e040ebfdde08911696a13d5">ISCA2-Related Mitochondrial Disorder - GeneReviews®</a><div class="ralinkpop offscreen_noflow">ISCA2-Related Mitochondrial Disorder - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:37:03-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal103&amp;ncbi_phid=CE8A25BDE0406A310000000003410143&amp;ncbi_session=CE8A25BDE040EBE1_0833SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK481904%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK481904&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK481904/&amp;ncbi_pagename=ISCA2-Related Mitochondrial Disorder - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8A25BDE040EBE1_0833SID /projects/books/PBooks@5.22 portal103 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>